产品介绍
Product Description
Application
VAHA may be used in cell signaling studies.
Biochem/physiol Actions
Hydroxamic acid derivatives of valproic acid exhibit anticonvulsant activity with no teratogenic activity in mouse neural tube defect model. It is effective in the treatment of bipolar disorders.
VAHA (Valproyl hydroxamic acid) is an HDAC inhibitor with less activity than valproic acid against Class I enzymes but much greater Class II activity
VAHA is an HDAC inhibitor
Features and Benefits
This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
技术参数
Specifications
| Quality Segment | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| solubility | DMSO: ≥25 mg/mL |
| storage temp. | 2-8°C |
| SMILES string | CCCC(CCC)C(=O)NO |
| InChI | 1S/C8H17NO2/c1-3-5-7(6-4-2)8(10)9-11/h7,11H,3-6H2,1-2H3,(H,9,10) |
| InChI key | ROJGIRXXBBBMPL-UHFFFAOYSA-N |
